The Ledger
Every statement that passed quotation and attribution checks. Mix any filter with any other: certainty 1/5, debate potential 5/5, or both at once.
why aren't all 9 resolved? a statement only gets an assessment when the public record can support or contradict it. opinions and what-ifs never can, and 0 checkable ones are still open, waiting for their date. predictions held up or didn't; assertions are supported or contradicted. on every card: ▮▮▮▮▮ certainty · ▮▮▮▮▮ debate potential. speakers are clickable
Lopez: Dog Breeds Living Near Golf Courses Suffer Higher Bladder Cancer Rates
“Certain breeds near golf courses have had actually bladder cancer, transitional cell carcinoma, it's actually an area of study.”
Lopez: One Health built the first NGS panel for dogs
“We have the first next gen sequencing panel for dogs.”
Lopez: Canine Genomics Lacks NIH Research Funding Compared to Mouse Models
“Veterinary medicine has not had the resources, and even from the NIH level, what the mouse has been very well characterized and studied, the dog really hasn't.”
Lopez: Spontaneous Canine Cancers Have Intact Immune Systems Missing in Mice
“Dogs that have natural disease, spontaneous disease, have an immune system also that's working, and that's a radical difference from the mice models that are much more engineered and sometimes don't have an immune system to have the cancer, and then the ones t…”
Lopez: Canine trials saved the development of lymphoma drug ibrutinib
“And you know the story of rebrutinib, a lymphoma drug that, you know, the dog and the human, and actually the evidence from the dog helped not just this company be alive, but the drug be alive”
Christina Lopez: Canine cancer probability increases significantly after age five
“And if you correlate cancer with aging, the dogs after the age of even five, the probability of cancer goes way up.”
Lopez: Veterinary oncology relies on only 13 total cancer therapies
“The toolbox is probably 13 therapies in total that we were talking about with Cheryl London, one of our KOLs that's really top in canine oncology, total.”